Screener
Harmony Biosciences Holdings, Inc. HRMY Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 8:16 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056720
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accrued expenses | 150,107 | 191,039 |
| Current portion of long-term debt | 20,000 | 20,000 |
| Other current liabilities | 11,907 | 4,957 |
| Total current liabilities | 217,340 | 252,132 |
| NONCURRENT LIABILITIES: | ||
| Long-term debt, net | 138,814 | 143,663 |
| Other noncurrent liabilities | 5,321 | 5,618 |
| Total noncurrent liabilities | 144,135 | 149,281 |
Item 1. Financial Statements
FAQ
- What is Harmony Biosciences Holdings, Inc.'s total current liabilities?
- Harmony Biosciences Holdings, Inc. (HRMY) reported total current liabilities of $217.34M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s total current liabilities changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s total current liabilities increased by 24.1% year-over-year, from $175.12M to $217.34M.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s total current liabilities has grown at a 13.4% compound annual growth rate (CAGR), from $134.54M to $252.13M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Harmony Biosciences Holdings, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude